Generate and translate clinical evidence into value propositions, usage algorithms, and clinical‑economic arguments that facilitate adoption across Clinical, Marketing, and Commercial functions, applying strong methodological rigor and a patient‑centric approach

Key Accountabilities

• Assess the diagnostic impact in CTD of four different algorithms/workflows (IFA versus Aptiva solid‑phase technology).
• Identify and address unmet needs in myositis diagnostics, transitioning from low‑confidence blot assays to quantitative Aptiva testing with improved sensitivity and specificity.
• Evaluate the clinical impact of using dsDNA testing on Aptiva for diagnosis and BIO‑FLASH for patient monitoring, leveraging two complementary technologies/platforms.
• Work collaboratively with Business Unit Product Managers, Clinical Specialists, R&D, and the Business Unit Manager to deliver actionable outcomes.

Networking/Key r...